Cannabinoids/Roselipin 3E Endocannabinoids
Roselipin 3E
Definition: CHEBI:202037 · Chemical Entities of Biological Interest↗ · release 253
[(2R,3S,4R)-1,3,4,5-tetrahydroxypentan-2-yl] 5,9-dihydroxy-2,4,6,8,10,12,14,16,18-nonamethyl-13-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosa-2,6,10,14-tetraenoateRoselipin 3E
0public articles
0registered condition areas
Identity & provenance
Chemical identity
C40H70O14 · molecular weight 774.986
CHEBI: CHEBI:202037↗CHEMSPIDER: chemspider:78445502↗INCHI: InChI=1S/C40H70O14/c1-11-20(2)12-21(3)13-26(8)38(54-40-37(50)36(49)35(48)31(19-43)53-40)27(9)15-24(6)32(45)22(4)14-23(5)33(46)25(7)16-28(10)39(51)52-30(18-42)34(47)29(44)17-41/h13-16,20-22,25,27,29-38,40-50H,11-12,17-19H2,1-10H3/t20?,21?,22?,25?,27?,29-,30-,31-,32?,33?,34+,35-,36+,37+,38?,40+/m1/s1↗INCHIKEY: JFXVPWSIWULGDZ-SHPANJRNSA-N↗PUBCHEM_CID: 139584431↗ Sources: ChEBI · 253↗PubChem computed properties · pug-9b76c399954744e4↗
0 referenced plant-occurrence records. They are identity candidates, not clinical evidence.
Research areas
Conditions found alongside this compound
Document links and organism occurrence are candidates, not proof of efficacy, safety or a treatment recommendation.
No published condition report is linked yet.
Linked local records
Medicines and registered studies
Links use source-reported active ingredients or study intervention names and remain candidates, not treatment claims.
Medicines with this active ingredient
No public medicine record matched.
Registered studies
0 exact source-intervention matches.
No registered study intervention matched.
Latest documents
Recent research